breast-neoplasms

Documents about breast-neoplasms

• Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer#884503ClinicalTrials.gov
• Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy#800942ClinicalTrials.gov
• Axillary Management After Neoadjuvant Chemotherapy#968892ClinicalTrials.gov
• Ultrasound vs. Predetermined Distance Techniques for Paravertebral Nerve Block in Patients Having Breast Surgery#1031210ClinicalTrials.gov
• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer#245486ClinicalTrials.gov
• Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer#841675ClinicalTrials.gov
• Chlorhydrate of Ropivacaine and Breast Cancer Surgery#885890ClinicalTrials.gov
• Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer Patients#904376ClinicalTrials.gov
• Quality of Life in Breast Cancer Patients and Survivors#1032619ClinicalTrials.gov
• Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor Excision#839003ClinicalTrials.gov
• Circulating Osteocalcin-positive Cells in Breast Cancer Bone Metastasis#910166ClinicalTrials.gov
• Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.#915934ClinicalTrials.gov
• Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer Patients#893254ClinicalTrials.gov
• Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer#67894ClinicalTrials.gov
• Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer#967698ClinicalTrials.gov
• Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer#18757ClinicalTrials.gov
• The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer#831198ClinicalTrials.gov
• NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer#871807ClinicalTrials.gov
• Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer#1010917ClinicalTrials.gov
• SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers#827218ClinicalTrials.gov
• Efficacy of Preoperative Radiotherapy for Non-responder Patients After Neoadjuvant Chemotherapy#834641ClinicalTrials.gov
• Tell us Your Food Story#858460ClinicalTrials.gov
• Imaging Study for FdCyd and THU Cancer Treatment#842727ClinicalTrials.gov
• Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing Positively#877358ClinicalTrials.gov
• GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer#855772ClinicalTrials.gov
• Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery#303656ClinicalTrials.gov
• Magnetic Occult Lesion Localization and Imaging (MOLLI)#855334ClinicalTrials.gov
• Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer#873938ClinicalTrials.gov
• Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study#889431ClinicalTrials.gov
• Effects on the Personalized Rehabilitation Service in Patients With Cancer#898690ClinicalTrials.gov
• Breast and Cervical Cancer Awareness Training in Visually Impaired Women#915727ClinicalTrials.gov
• Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery#383568ClinicalTrials.gov
• Correlation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant Chemotherapy#852081ClinicalTrials.gov
• Chronic Pain After Operation for Breast Cancer#898871ClinicalTrials.gov
• RISS Versus SPSIP Block in Modified Radical Mastectomy#970040ClinicalTrials.gov
• PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer#1007613ClinicalTrials.gov
• Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors#1008009ClinicalTrials.gov
• The Breast Surgery EnLight and LightPath Imaging System Study#864515ClinicalTrials.gov
• Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer#802436ClinicalTrials.gov
• A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine#825074ClinicalTrials.gov
• Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer#837570ClinicalTrials.gov
• Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients#852708ClinicalTrials.gov
• The Patterns of Activity and Cognition During Treatment (PACT) Study#882935ClinicalTrials.gov
• Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer#329485ClinicalTrials.gov
• "neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer#174862ClinicalTrials.gov
• Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer#407727ClinicalTrials.gov
• Impact of Acceptance and Commitment Therapy on Early Stage Breast Cancer#812740ClinicalTrials.gov
• Behavioral Symptom Management Program for Breast Cancer in Singapore and The US#840295ClinicalTrials.gov
• Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer#869235ClinicalTrials.gov
• Unmet supportive care needs of young women with breast cancer in Chile during follow-up stage after treatment: A qualitative study#437668Repositorio Universidad del Desarrollo